Stay updated on Preventing GvHD in Allo ApoGraft SCT - Clinical Trial
Sign up to get notified when there's something new on the Preventing GvHD in Allo ApoGraft SCT - Clinical Trial page.

Latest updates to the Preventing GvHD in Allo ApoGraft SCT - Clinical Trial page
- Check3 days agoChange DetectedThe record history now shows explicit Last verified and Last known status were fields and lists the current revision as v3.6.0, replacing the previous revision v3.5.5.SummaryDifference2%

- Check10 days agoChange DetectedA new revision entry v3.5.5 was added, replacing the previous revision v3.5.4. This is a platform update and does not modify the study record data.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedA new revision entry v3.5.4 has been added to the record history, replacing the previous v3.5.3. This reflects a minor update to the historical record rather than changes to the study data.SummaryDifference0.1%

- Check46 days agoChange DetectedThe record history now lists Revision: v3.5.3, indicating an updated version of the study record metadata.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision v3.5.2 was added to the history and Revision v3.5.0 was removed.SummaryDifference0.1%

- Check89 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the site; no user-visible content or data changes are indicated in the screenshot.SummaryDifference0.1%

Stay in the know with updates to Preventing GvHD in Allo ApoGraft SCT - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Preventing GvHD in Allo ApoGraft SCT - Clinical Trial page.